IMUX
IMUX
NASDAQ · Biotechnology

Immunic Inc

$7.96
-0.68 (-7.87%)
As of Oct 3, 2:33 AM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +210.2% upside
Low Target $14.59
Average Target $24.69
High Target $25.91
Current Price $7.96
Current
$7.96
Target
$24.69
$14.59 $24.69 avg $25.91
Scenario Analysis
Bear Case
$14.59
83.3%
Low target
Base Case
$24.69
+210.2%
Avg target
Bull Case
$25.91
+225.5%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$17.43
-54.3% from high
52-Week Low
$5.06
+57.3% from low
Target vs 52W High
$24.69
+41.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.0%
AMGN
Amgen Inc
Hold 43 47% $190.87 -52.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +150.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -13.2%
MRNA
Moderna Inc
Hold 30 37% $149.45 -21.3%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.8%